Seegene씨젠
096530 · KOSDAQ · ₩096530 · 씨젠
₩33,500▲ ₩700 (2.13%)End-of-day · Oct 28, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩474B | ₩414B | ₩367B | ₩854B | ₩1.4T |
| Cost of sales | ₩170B | ₩176B | ₩155B | ₩357B | ₩366B |
| Gross profit | ₩304B | ₩239B | ₩212B | ₩496B | ₩1T |
| Operating income | ₩35B | −₩16B | −₩30B | ₩196B | ₩667B |
| Net income | ₩48B | −₩20B | ₩733M | ₩182B | ₩538B |
| Net income to shareholders | ₩48B | −₩20B | ₩669M | ₩182B | ₩537B |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩1.2T | ₩1.2T | ₩1.3T | ₩1.4T | ₩1.5T |
| Current assets | ₩799B | ₩746B | ₩783B | ₩903B | ₩1.1T |
| Cash and equivalents | ₩226B | ₩260B | ₩190B | ₩521B | ₩432B |
| Total liabilities | ₩220B | ₩224B | ₩221B | ₩240B | ₩406B |
| Current liabilities | ₩171B | ₩161B | ₩162B | ₩170B | ₩287B |
| Borrowings | ₩76B | ₩77B | ₩77B | ₩83B | ₩84B |
| Total equity | ₩1T | ₩981B | ₩1T | ₩1.2T | ₩1.1T |
| Shareholders' equity | ₩1T | ₩979B | ₩1T | ₩1.1T | ₩1.1T |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | ₩149B | ₩85B | ₩95B | ₩319B | ₩334B |
| Capital spending | ₩37B | ₩40B | ₩25B | ₩63B | ₩62B |
| Free cash flow | ₩112B | ₩45B | ₩70B | ₩256B | ₩272B |
| Dividends paid | ₩37B | ₩37B | ₩38B | ₩51B | ₩70B |
Consolidated where available. Amounts in won.
Also known as: Seegene / 씨젠 / 096530 / KRX:096530
Source: KRX statistical information